ORIGINAL RESEARCH article
Front. Cell Dev. Biol.
Sec. Stem Cell Research
Volume 13 - 2025 | doi: 10.3389/fcell.2025.1626353
This article is part of the Research TopicAdvances in Perinatal Stem Cells Research and ApplicationsView all articles
Wharton's jelly mesenchymal stromal cells derived from preterm umbilical cord reveal a hepatogenic potential
Provisionally accepted- 1Ri.MeD, Palermo, Italy
- 2university of Palermo, Palermo, PA, Italy
- 3University of Texas, Galveston, United States
- 4ISMETT, Palermo, Italy
- 5Unicamillus, Roma, Italy
- 6University of Palermo, Palermo, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The umbilical cord (UC) is a perinatal tissue from which it is possible to isolate mesenchymal stromal cells (MSCs) with a higher proliferation rate and a higher differentiation capacity compared to their adult counterparts. Wharton's jelly (WJ) is a rich source of multipotent and hypoimmunogenic MSCs (WJ-MSCs), which are considered promising candidates for cell therapy of many conditions, including liver diseases. Preterm umbilical cord (birth before 37 weeks of gestation) is generally considered a waste product, so its use does not affect ethical issues. Similarly to the fullterm UC, it can be considered a valid source of WJ-MSCs, although little is known about their phenotype and differentiation capacity.We aim to show that WJ-MSCs derived from preterm umbilical cords exhibit comparable characteristics to their mature counterparts and, in particular, show a similar ability to differentiate into hepatocyte-like cells and retain hypoimmunogenicity features. Both these aspects may be key in the prospective application of these cells in regenerative medicine.Here, we isolated WJ-MSCs from seven prematurely harvested umbilical cords (pWJ-MSCs). We assessed a mesenchymal phenotype and differentiation potential by flow cytometry, immunocytochemistry, and immunofluorescence. A standardized liver differentiation protocol was performed, and the acquisition of the hepatic phenotype was assessed by characterization of hepatic protein expression and functional assays.We demonstrated that pWJ-MSCs exhibited mesenchymal characteristics, acquired phenotypical and functional features of hepatocytes when induced to differentiate in a specific medium, and maintained the expression of immunomodulatory molecules.Discussion: This study showed that even if pregnancy has been interrupted before the 22 nd week, p-WJ-MSCs had the same differentiative ability as the counterpart derived from the full-term UC, that we have previously demonstrated, and can be considered a valid cellular population for liver cell therapy.
Keywords: Wharton's jelly, Mesenchymal Stromal Cells, preterm umbilical cord, hepatogenic potential, Immune Modulation, Liver Diseases, Therapeutic abortion
Received: 10 May 2025; Accepted: 11 Jun 2025.
Copyright: © 2025 Timoneri, Lo Iacono, Corrao, Alberti, Amico, Corsello, Conaldi, Russo and La Rocca. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Melania Lo Iacono, university of Palermo, Palermo, PA, Italy
Giampiero La Rocca, University of Palermo, Palermo, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.